Dietary supplementation with a designer metabolic modulator improves MASLD and associated anxiety in mice
These results suggest that α5 represents a novel intervention to prevent or mitigate the progression of MASLD and its associated mental health complications.
Authors
- Agnese Segala (ORCID: https://orcid.org/0000-0002-9744-4681)
- Enzo Nisoli (ORCID: https://orcid.org/0000-0002-6670-1630)
- Edoardo Parrella (ORCID: https://orcid.org/0000-0003-0365-5144)
- Emanuela Bottani (ORCID: https://orcid.org/0000-0003-1217-8722)
- Gaia Favero (ORCID: https://orcid.org/0000-0001-6895-7106)
- Emirena Garrafa (ORCID: https://orcid.org/0000-0003-4761-6892)
- Maurizio Ragni (ORCID: https://orcid.org/0000-0001-6548-741X)
- Alessandra Valerio (ORCID: https://orcid.org/0000-0001-5844-2256)
- Rita Rezzani (ORCID: https://orcid.org/0000-0002-7515-5846)
- Chiara Ruocco (ORCID: https://orcid.org/0000-0002-6544-2067)
- Alice Vetturi
Institutions
- University of Verona (IT)
- University of Milan (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.3389/fphar.2025.1661939
- Citations
- 1
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Fondazione Umberto Veronesi
- Università degli Studi di Brescia